SENASA opens registration for the veterinary analgesic Relaxicam 4mg

The National Animal Health Service (SENASA), through its Department of Veterinary Medicines, published an edict in La Gaceta — Official Gazette on Thursday, September 3, 2026, to register the veterinary product Rx Relaxicam 4mg, an analgesic and anti-inflammatory intended for dogs and cats. The application was submitted by the veterinary regent Ayelet Gómez Sirias, representing the company VIA-AGRO S.A., and is being processed under reference DMV-RGI-R-1079-2026.

The edict, signed in Heredia on August 19, 2026, by Dr. Julián Pastor Pacheco, summons third parties with the right to object to assert their interests before the Department within a period of five business days, counting from the day following the publication in the Official Gazette.

The product and its manufacturer

The medication Rx Relaxicam 4mg is manufactured by Holland de México SA DE CV, from Mexico, and belongs to group 3 of veterinary products. Its active ingredient is meloxicam 4 mg per tablet, with therapeutic indications as an analgesic and anti-inflammatory for use in dogs and cats.

The product information complies with the requirements of the Central American Technical Regulation RTCA 65.05.51:18, regarding veterinary medicines, related products, and their establishments, as well as the sanitary registration and control requirements established in Executive Decree Nº 42965-COMEX-MEIC-MAG.

Application data

• Applicant: Ayelet Gómez Sirias, identity card 1-1257-0366, veterinary regent of VIA-AGRO S.A.
• Address: Servicentro Sheyza, 100 m east, avenue Nº 42 between street Nº 131 and street Nº 130, Costa Rica
• Product: Rx Relaxicam 4mg (group 3)
• Active ingredient: meloxicam 4 mg/tablet
• Indications: analgesic and anti-inflammatory for dogs and cats
• Opposition period: 5 business days from the day following publication

Opposition procedure

Those who consider themselves to have the right to oppose the registration must present their claim before the SENASA Department of Veterinary Medicines within the specified term. The edict is published once in the Official Gazette, in accordance with the current sanitary registration procedure for veterinary medicines in the country.

The publication of this edict is part of the ordinary registration process for veterinary products, which allows interested third parties to exercise their right of opposition before the medication is registered and can be marketed within the national territory.

Source: La Gaceta — Official Gazette, Nº 166, Thursday, September 3, 2026, Miscellaneous Documents section (official reference: IN202601119342).